Skip to evidence report

B.memory.preactivated: Studies

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 1,977 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 1–1,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for B.memory.preactivated
#Trait / studyIndividual trait IDMean IC score
1TCL1A levelsGCST9047081787.05
2N-delta-acetylornithine levelsGCST9020069182.86
3PARP1/TCL1A ratioGCST9031560272.74
4FCER2/TREML2 ratioGCST9031479272.69
5FCRL2 levelsGCST9046920670.77
6FCRL1 levelsGCST9046920565.82
7FCER2 levelsGCST9046919965.15
8Multiple myeloma or monoclonal gammopathy of undetermined significanceGCST9062474665.11
9IL5RA levelsGCST9046960064.78
10CD22 levelsGCST9046861064.12
11Pain in limbFING0000113863.73
12CD27/TNFRSF13B ratioGCST9031377763.27
13JCHAIN levelsGCST9046966163.02
14Incidence of bisecting GlcNAc in all fucosylated disialylated structures (GP57)GCST9066873561.13
15ZNRD2 levelsGCST9047110360.73
16Lymphoid neoplasms (P-cell phenocluster)GCST9062473759.01
17FCRL5/LY96 ratioGCST9031480357.53
18TNFRSF13B/TNFRSF9 ratioGCST9031593256.06
19Systemic lupus erythematosusGCST9001186656.04
20TCL1A/TNFRSF13C ratioGCST9031591255.86
21TNFRSF13B/TNFSF13B ratioGCST9031593354.78
22CD72 levelsGCST9046864654.15
23FCER2/TNFRSF9 ratioGCST9031479153.95
24Percentage of fucosylation of monogalactosylated structures in total neutral plasma glycans (GP74)GCST9066851851.72
25TNFSF13B levelsGCST9047092051.31
26FCER2/FCRL1 ratioGCST9031478951.16
27CD5L levelsGCST9046864050.95
28Rheumatoid arthritisGCST9001869049.59
29TNFRSF13C levelsGCST9047090649.46
30KIF22 levelsGCST9046968248.97
31SLAMF1 levelsGCST9027483548.49
32INPP5J levelsGCST9046961848.42
33IL18RAP levelsGCST9046956646.58
34UGDH levelsGCST9047100646.32
35Multiple myelomaGCST9062474746.01
36SEPTIN3 levelsGCST9047057644.88
37TNFRSF13B levelsGCST9047090544.37
38Paraproteinemia (PheCode 270.32)GCST9047571041.98
39Monoclonal gammopathy of undetermined significanceGCST9062474541.83
40Non-albumin protein levelsUKBB0000050341.29
41CD22/SEMA7A ratioGCST9031375940.90
42Other soft tissue disorders, not elsewhere classifiedFING0000109940.80
43DTI TBSS FA Sagittal stratum LGCST9038441140.14
44CR2/TNFRSF13B ratioGCST9031422538.88
45FCRL5/TNFRSF13B ratioGCST9031480538.68
46Kela-code for severe mental illnessFING0000070738.07
47Left ventricular end systole inferior wall thicknessGCST9027850937.86
48Rheumatoid arthritisGCST9013222437.63
49FCER2/TCL1A ratioGCST9031479037.56
50Physical activity (confirmatory factor analysis Factor 23)GCST9030935737.32
51CD22/TCL1A ratioGCST9031376037.05
52ALB/Globulin ratioUKBB0000002036.82
53CD79B/TNFRSF13B ratioGCST9031390236.29
54FCRL1/TCL1A ratioGCST9031479535.32
55FCRL2/TNFRSF13B ratioGCST9031480135.23
56Primary biliary cholangitisGCST9006144034.54
57FCRL1/TREML2 ratioGCST9031479734.52
58Disorders of plasma protein metabolism (PheCode 270.3)GCST9047570934.44
59FCRL2/SEMA7A ratioGCST9031480034.12
60Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)GCST9013222733.62
61Lymphoid neoplasms (somatic mutation group 2 phenocluster)GCST9062475033.42
62Blood cell traits latent factor 23 (white cell)GCST9055926533.12
63Urine X-24796 levels in chronic kidney diseaseGCST9026680033.06
64Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders (more control exclusions)FING0000010132.54
65Sleep durationGCST00383932.32
66TP53BP1 levelsGCST9047093631.12
67CD27/TNFRSF9 ratioGCST9031377831.09
68T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 4)GCST9032082330.98
69Moderate to vigorous physical activity durationGCST9006142230.79
70Bifidobacterium kashiwanohense abundance in stoolGCST9003222630.31
71MZB1/TNFRSF13B ratioGCST9031550929.87
72TNFRSF17 levelsGCST9047090829.82
73Chronic lymphocytic leukemiaGCST9062473828.79
74Colitis, primary sclerosing, strict definitionFING0000031328.64
75Lymphocyte countGCST9000238828.61
76TXNDC15 levelsGCST9047099028.49
77UrticariaFING0000140828.43
78Lymphoid neoplasms (B-cell phenocluster)GCST9062473628.23
79Lymphocyte countGCST00462728.20
80FCRL1/TNFRSF13C ratioGCST9031479628.15
81Enthesopathies of lower limb, excluding footFING0000050927.85
82Blood cell traits latent factor 17 (white cell)GCST9055925927.77
83PEAR1/TREML2 ratioGCST9031564527.60
84CTSO levelsGCST9046891527.00
85IDP dMRI ProbtrackX L1 cgc lGCST9000425026.61
86Fibrosis and cirrhosis of liverFING0000054326.46
87Lymphocyte count (UKB data field 30120)GCST9046808226.41
88Lymphocyte countGCST9000231626.28
89Personal history of allergy to drugs, medicaments and biologocal substances | Persons with potential health hazards related to family and personal history and certain conditions influencing health statusUKBB0000064126.21
90Systemic lupus erythematosusGCST9001423826.19
91Champagne or white wine consumption (glasses per month) (UKB data field 1578, 4418)GCST9013298625.94
92CALCOCO1/MAP3K5 ratioGCST9031360525.92
93Sleep apneaGCST9047582425.89
94Lymphoid neoplasms (drug group 1 phenocluster)GCST9062474025.68
95CR2 levelsGCST9046885225.65
96CD83/IL12A_IL12B ratioGCST9031390525.62
97QPCT/RNASET2 ratioGCST9031575825.58
98ICAM3/TNFRSF13B ratioGCST9031512425.57
99FCRL2/LY9 ratioGCST9031479925.44
100Lymphocyte count | Blood countUKBB0000041125.34
101IDP T1 FAST ROIs L cerebellum VGCST9000256425.31
102NINJ1 levelsGCST9047004925.30
103Medication use (immunosuppressants)GCST9001877125.08
104LILRB1 levelsGCST9046977624.81
105IL5RA/TNFRSF13B ratioGCST9031516424.50
106X-03056--N-[3- 2-Oxopyrrolidin-1-yl propyl]acetamide levelsGCST9024361924.48
107PRCP levelsGCST9047031424.17
108TNFRSF13B/TNFRSF13C ratioGCST9031593124.15
109S100A11/S100A12 ratioGCST9031579824.08
110Types of physical activity in last 4 weeks - Strenuous sports | Physical activityUKBB0000087423.85
111Primary biliary cholangitisGCST00312923.68
112WASL levelsGCST9047107023.67
113Sicca syndrome [Sjögren]FING0000130423.59
114Biological Sibling: Cancer, SkinGCST9047636923.52
115BLNK levelsGCST9046844823.44
116Lymphocyte countGCST9000231723.42
117IL16 levelsGCST9046955723.29
118Lifetime number of sexual partners | Sexual factorsUKBB0000040622.93
119Myasthenia gravisGCST9043215622.87
120rfMRI connectivity (ICA25 edge 103)GCST9000474622.83
121CD22/FCER2 ratioGCST9031375622.63
122SERPINA9 levelsGCST9047058822.62
123F-meat liking (derived food-liking factor)GCST9009479922.59
124SORT1/ST6GAL1 ratioGCST9031586922.41
125PLXNA4/USP8 ratioGCST9031569022.37
126Lymphoid leukemia, chronic (PheCode 204.12)GCST9047561322.09
127TRAF3 levelsGCST9047095722.02
128CD79B/TNFRSF4 ratioGCST9031390321.92
129Occupational attainmentGCST9010225321.87
130IGLC2 levelsGCST9046953621.80
131Idiopathic pulmonary fibrosisFING0000065921.76
132Primary biliary cholangitis (PBC)FING0000121121.53
133MBL2 levelsGCST9046986821.46
134Time spend outdoors in summer | Sun exposureUKBB0000081721.38
135PDCD1/TNFRSF8 ratioGCST9031561021.26
136GART levelsGCST9046930321.26
137PCSK7 levelsGCST9047017620.96
138CRYBB2 levelsGCST9046887520.94
139Pre-existing hypertension complicating pregnancy, childbirth and the puerperiumFING0000120320.90
140MMP1/SERPINB6 ratioGCST9031546220.70
141Qualifications - Other professional qualifications eg: nursing, teaching | EducationUKBB0000073220.53
142CCL5/TACC3 ratioGCST9031370720.49
143Multiple myeloma and malignant plasma cell neoplasms (controls excluding all cancers)FING0000084320.46
144Risk taking | Mental healthUKBB0000075920.39
145FKBP7 levelsGCST9046924520.37
146Secondary hypothyroidism (PheCode 244.1)GCST9047564920.33
147MYCT1 levelsGCST9061804620.31
148CD22/FCRL1 ratioGCST9031375720.30
149Bread type - Wholemeal or wholegrain | DietUKBB0000010720.26
1503,5-dichloro-2,6-dihydroxybenzoic acid levelsGCST9020025220.25
151CD27 levelsGCST9046861520.23
152ATP5IF1/LYN ratioGCST9031338920.23
153Number of vehicles in household | HouseholdUKBB0000054319.99
154Treatment or medication use - insulin product (UKB data field 20003_1140883066)GCST9004222619.98
155Benign neoplasm of other and unspecified endocrine glandsFING0000015919.98
156DepressionFING0000039819.93
157C9 Carnitine levels in chronic kidney diseaseGCST9025768219.89
158ZNF830 levelsGCST9047110219.79
159CD79B/FCRL1 ratioGCST9031389919.79
160Lymphoid neoplasmsGCST9062474319.68
161Diacylglycerol_33:1_[M+H-H2O]1+ levelsGCST9006017319.64
162MCTS1 levelsGCST9046987419.49
163Leisure/social activities - Other group activity | Social supportUKBB0000040019.31
164IBD (strict) with PSCFING0000065719.29
165Impacted cerumen (PheCode 380.4)GCST9047590119.29
166Hypercalcemia (PheCode 275.6)GCST9047574819.29
167EFNA4/VWC2 ratioGCST9031460719.20
168Lymphoid leukaemia (controls excluding all cancers)FING0000074119.19
169wg rh intensity-contrast lingualGCST9000383919.13
170Wears glasses or contact lenses | EyesightUKBB0000090719.11
171Left ventricular end systole anterolateral wall thicknessGCST9027851119.03
172CD22/FOLR2 ratioGCST9031375819.00
173Seropositive rheumatoid arthritis, wideFING0000129818.98
174mean corpuscular hemoglobin (MCH, mean, inv-norm transformed)GCST9047544418.96
175FCGR2A levelsGCST9046920018.91
176Fracture of radius and ulna (PheCode 803.2)GCST9047628018.90
177TNFRSF13C/TNFSF13B ratioGCST9031593418.89
178LY96 levelsGCST9046982318.87
179Plasma argininate* levels in chronic kidney diseaseGCST9026482618.85
180CD27/TGFBR2 ratioGCST9031377618.80
181Number of days/week walked 10+ minutes | Physical activityUKBB0000053518.77
182CD209/CLEC14A ratioGCST9031374918.71
183Varicose veins of lower extremity, symptomtic (PheCode 454.11)GCST9047601418.62
184T1 FreeSurfer DKT rh insula areaGCST9038431718.53
185CD27/NBL1 ratioGCST9031377418.49
186PGR levelsGCST9047022318.47
187NUBP1 levelsGCST9047010018.43
188Qualifications - None of the above | EducationUKBB0000072918.42
189Percentage of FA2G1 in total neutral plasma glycans (GPn) (GP61)GCST9066850518.14
190ADAM23 levelsGCST9024092218.06
191CD48 levelsGCST9042567618.01
192Qualifications - O levels/GCSEs or equivalent | EducationUKBB0000073118.00
193Irritable bowel syndromeGCST9001656417.98
194SSC-A on plasmacytoid Dendritic CellGCST9000207217.95
195GZMA/IL12A_IL12B ratioGCST9031500917.89
196DTI TBSS L2 Sagittal stratum LGCST9038450717.87
197Seminoma of testis, excluding all cancers (controls excluding all cancers)FING0000128917.86
198mean corpuscular hemoglobin (MCH, minimum, inv-norm transformed)GCST9047544817.82
199CRTAP levelsGCST9046887217.79
200FCRL5/ICAM3 ratioGCST9031480217.72
201IL2RA levelsGCST9046958517.69
202Ceramide (d16:1/22:0) levelsGCST9002402617.61
203Strenuous sports or other exercisesGCST00610017.61
204ThalamNuclei rh volume MGNGCST9000273717.45
205FCRL5 levelsGCST9046920817.27
206Diseases of middle ear and mastoidFING0000042717.18
207Multiple sclerosisGCST9047583317.07
208Operation code - wisdom teeth surgery | OperationsUKBB0000056917.03
209lymphocyte (absolute count, mean, inv-norm transformed)GCST9047542616.99
210EDA2R levelsGCST9046906716.97
211Right ventricular ejection fractionGCST9013459116.92
212Rheumatoid arthritisGCST00067916.91
213Plasma succinylcarnitine (C4-DC) levels in chronic kidney diseaseGCST9026599816.89
214CA1/CA3 ratioGCST9031357216.88
215Bread type - White | DietUKBB0000010616.87
216Mother's age | Family historyUKBB0000048416.74
217Bifidobacterium catenulatum abundance in stoolGCST9003222416.73
2185alpha-androstan-3alpha,17beta-diol monosulfate (1) levelsGCST9019985816.70
219Influenza and pneumoniaFING0000067916.69
220Experiencing mood swingsGCST00694416.60
221Ulcerative colitisGCST00413316.57
222CALCOCO1/CRACR2A ratioGCST9031359816.50
223lymphocyte (absolute count, minimum, inv-norm transformed)GCST9047542916.45
224Broad bean likingGCST9009471116.43
225Age completed full time education | EducationUKBB0000001316.41
226Triacylglycerol_50:2_[M+NH4]1+ levelsGCST9006047316.38
227T1 CAT volume L LeftAccumbensGCST9038410816.35
228PIKFYVE levelsGCST9047023516.32
229Osteoarthrosis (PheCode 740)GCST9047625316.30
230Red meat likingGCST9009481916.24
231AFP levelsGCST9046825016.17
232HNRNPK/USP8 ratioGCST9031507016.15
233Rheumatoid arthritisGCST9013222316.05
234THY1 levelsGCST9047086116.03
235wg rh intensity-contrast pericalcarineGCST9000384715.83
236C2 levelsGCST9046849715.77
237Moderate-to-vigorous intensity physical activity during leisure timeGCST9010434115.70
238Cough on most days | Medical informationUKBB0000015315.70
239Triacylglycerol_50:3_[M+NH4]1+ levelsGCST9006046815.67
240TOP1 levelsGCST9047093315.62
241X-11444 metabolite levelGCST9061654515.52
242Mood [affective] disordersFING0000083615.52
243CD40/TNFRSF14 ratioGCST9031383015.47
244Principal component-derived dietary pattern 42GCST9013304715.45
245CD101 levelsGCST9046859615.43
246Cereal type - Other (e.g. Cornflakes, Frosties) | DietUKBB0000012515.36
247Unspecified dementiaFING0000140015.27
248Cardiorespiratory fitness (vo2 max)GCST9009331715.24
249CLPP/DECR1 ratioGCST9031413715.20
250Percentage of fucosylated structures (with bisecting GlcNAc) in total neutral plasma glycans (GP80)GCST9066875815.20
251Psoriasis vulgarisGCST9001868715.13
252GHRL levelsGCST9046934115.10
253Hereditary hemolytic anemias (PheCode 282)GCST9047577915.10
254Operative procedures - Closed reduction of fracture of bone and fixation using nail or screw | Summary OperationsUKBB0000057515.02
255CALCOCO1/TBC1D5 ratioGCST9031361015.00
256LGALS4 levelsGCST9046976214.95
257Treatment/medication code - ventolin 100micrograms inhaler | MedicationsUKBB0000086014.93
258ABL1/DNMBP ratioGCST9031314914.91
259CD27/DLL1 ratioGCST9031377114.90
260Qualifications - A levels/AS levels or equivalent | EducationUKBB0000072714.88
261Lymphocyte countGCST9002598414.71
262DTI TBSS L3 Posterior thalamic radiation RGCST9038455214.66
263Triacylglycerol_52:2_[M+NH4]1+ levelsGCST9006051114.64
264F-sauces liking (derived food-liking factor)GCST9009483114.63
265CRTAM/LY9 ratioGCST9031427814.63
266High myopiaGCST00996214.61
267IDP dMRI TBSS FA Retrolenticular part of internal capsule LGCST9000389814.58
268CHIT1 levelsGCST9046874414.53
269Methods of admission to hospital (recoded) - Elective admission: Booked | Summary AdministrationUKBB0000046114.53
270CD302/IL12A_IL12B ratioGCST9031380614.53
271T1 FreeSurfer aseg Right-CaudateGCST9038416214.48
272Left ventricular end systole inferoseptal wall thicknessGCST9027850814.45
273SLAMF1 levelsGCST9047064914.33
274CRTAM/ICAM3 ratioGCST9031427614.32
275Principal component-derived dietary pattern 8GCST9013301314.29
276ADM levelsGCST9001199614.29
277Thyrotoxicosis with diffuse goitreFING0000136114.27
278Ulcerative colitis (strict) with PSCFING0000138914.23
279BSG/IL12A_IL12B ratioGCST9031353214.23
280Triacylglycerol_51:2_[M+NH4]1+ levelsGCST9006049714.19
281Treatment/medication code - levothyroxine sodium | MedicationsUKBB0000084914.18
282Omega-3 fatty acids to Omega-6 fatty acids ratioGCST9050239614.18
283AIDA levelsGCST9046826514.17
284Seropositive rheumatoid arthritis, strict definitionFING0000129714.16
285FCER1A levelsGCST9046919814.15
286Total protein levelsUKBB0000082614.13
287Takes medication for Skin condition (ex. Eczema, Psoriasis)?GCST9047527514.10
288Lymphocyte countGCST9001874214.07
289Types of physical activity in last 4 weeks - Walking for pleasure (not as a means of transport) | Physical activityUKBB0000087514.05
290wg lh intensity-contrast caudalmiddlefrontalGCST9000379513.96
291Total protein levelsGCST9001875613.95
292Left ventricular end systole inferolateral wall thicknessGCST9027851013.89
293POMC levelsGCST9047028413.85
294CD74 levelsGCST9046864713.85
295Degenerative skin conditions and other dermatoses (PheCode 702)GCST9047620213.80
296KDM3A levelsGCST9046967113.75
297Triacylglycerol_53:2_[M+NH4]1+ levelsGCST9006053113.70
298Volume of right cortico-amygdaloid transition areaGCST9047501813.70
299Bread type: White (UKB data field 1448_1)GCST9013296413.69
300CLEC4G levelsGCST9046877413.66
301Osteoarthrosis NOS (PheCode 740.9)GCST9047625613.65
302Prescriptions - levothyroxine | thyroid hormoneUKBB0000068713.60
303Prescriptions - thyroid hormone | hormoneUKBB0000070513.60
304Other and unspecified tonsillitisFING0000095413.55
305Total protein levelsGCST9046810513.54
306ST13 levelsGCST9047075113.54
307Bread type: White vs wholemeal/wholegrain and brown (UKB data field 1448)GCST9013296713.52
308FOLR2 levelsGCST9046926013.52
309LRRC37A2 levelsGCST9046980213.48
310ARTN levelsGCST9046837213.41
311aparc-Desikan lh thickness paracentralGCST9000346113.38
312Nonspecific chest pain | circulatory systemUKBB0000052713.38
313Occupation and workplace environment (confirmatory factor analysis Factor 5)GCST9030934013.37
314CD79B/CKAP4 ratioGCST9031389813.36
315Volume of right basal nucleusGCST9047501213.34
316CD27/CD79B ratioGCST9031377013.28
317Percentage of FA2G1 in total neutral plasma glycans (GPn) (GP61)GCST9066873913.28
318EIF3J levelsGCST9024112213.27
319ERBB4/F3 ratioGCST9031469013.25
320Neurofibromatosis, type 2FING0000086713.24
321Disorders of orbitFING0000044913.21
322ThyrotoxicosisFING0000136013.20
323Aplastic anemia (PheCode 284)GCST9047578313.11
324Treatment or medication use - levothyroxine sodium (UKB data field 20003_1141191044)GCST9004253513.09
325REG3A levelsGCST9047044913.04
326Crisps likingGCST9009474713.00
327GFRA2/IL12A_IL12B ratioGCST9031492512.99
328Rheumatoid arthritisFING0000126712.96
329HippSubfield lh volume CA4-bodyGCST9000268312.93
330DTI TBSS FA Posterior thalamic radiation RGCST9038440812.89
331Principal component-derived dietary pattern 16GCST9013302112.88
332Bell pepper likingGCST9009470312.88
333CALCOCO1/IRAG2 ratioGCST9031360412.86
334CA3/HMBS ratioGCST9031358412.85
335Physical activity (Relative amplitude)GCST9006143212.85
336lymphocyte (absolute count, maximum, inv-norm transformed)GCST9047542312.84
337Hypothyroidism, drug reimbursementFING0000065512.84
338wg rh intensity-contrast cuneusGCST9000383112.81
339TNFRSF14/TNFSF14 ratioGCST9031593612.78
340CEACAM8/MMP9 ratioGCST9031400212.76
3411-(1-enyl-palmitoyl)-2-linoleoyl-GPE (p-16:0/18:2) levelsGCST9020007512.70
342CDKN2D/TACC3 ratioGCST9031399212.69
343Beetroot likingGCST9009470212.67
344Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)FING0000084612.67
345LILRB2 levelsGCST9046977712.62
346Percentage of monosialylation of core-fucosylated monogalactosylated structures without bisecting GlcNAc (GP41)GCST9066848512.59
347Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)FING0000075612.58
348DEFA1_DEFA1B/LCN2 ratioGCST9031445412.50
349Alcohol drinker status - Current | AlcoholUKBB0000002112.46
350Mood swings | Mental healthUKBB0000048212.45
351B2M levelsGCST9046840912.43
352Non-cancer illness code, self-reported - hypothyroidism/myxoedema | Medical conditionsUKBB0000051812.40
353Fed-up feelings | Mental healthUKBB0000024212.40
354Physical activity (Total log acceleration 10pm-12am)GCST9006142012.39
355Cereal type: Other (e.g. Cornflakes, Frosties) (UKB data field 1468_5)GCST9013297312.36
356TYRP1 levelsGCST9047099812.35
357EPHB6/VWC2 ratioGCST9031468312.32
358Number of incorrect matches in round | Pairs matchingUKBB0000053812.31
359Diacylglycerol_34:0_[M+H-H2O]1+ levelsGCST9006018112.23
360Non-seminoma of testis, excluding all cancers (controls excluding all cancers)FING0000087412.18
361How are people in household related to participant - Husband, wife or partner | HouseholdUKBB0000033012.09
362SFTPA1 levelsGCST9047061212.08
363CDKN1A/TACC3 ratioGCST9031397512.07
364Active to sedentary transition probabilityGCST9006142912.06
365CD38/IL12A_IL12B ratioGCST9031380812.02
366SPINT1/SUSD2 ratioGCST9031587811.98
367Ceramide (d18:2/22:0) levelsGCST9002468211.94
368ELOA/POLR2F ratioGCST9031464311.93
369PDCD1/TNFRSF9 ratioGCST9031561111.92
370Polyglandular dysfunctionFING0000118611.87
371Corneal edema (PheCode 364.2)GCST9047586211.86
372Skin and soft tissue infectionsGCST9001341111.86
373SNX2 levelsGCST9047070111.85
374Job involves mainly walking or standing | EmploymentUKBB0000038411.82
375ADH4/SCLY ratioGCST9031319511.82
376Types of physical activity in last 4 weeks - Other exercises (eg: swimming, cycling, keep fit, bowling) | Physical activityUKBB0000087311.77
377HippSubfield rh volume subiculum-bodyGCST9000269111.77
378IDP T1 FAST ROIs V cerebellum XGCST9000258811.74
379C1R levelsGCST9046849311.74
380Osteoarthritis, localized (PheCode 740.1)GCST9047625411.71
381Volume of right accessory basal nucleusGCST9047500611.70
382Thyroid problemsGCST9047527611.69
383Triacylglycerol_50:4_[M+NH4]1+ levelsGCST9006046611.68
384Spherical power (left) | AutorefractionUKBB0000079011.61
385Allergy/adverse effect of penicillin | injuries & poisoningsUKBB0000002811.59
386F-fruit liking (derived food-liking factor)GCST9009476711.52
387Spherical power (right) | AutorefractionUKBB0000079111.49
388T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 60)GCST9032062311.48
389Use of disulfiram, acamprosate or naltrexoneFING0000141011.48
390IPCEF1/TBCC ratioGCST9031518811.46
391SEPTIN8 levelsGCST9047057811.42
392Illness, injury, bereavement, stress in last 2 years - Financial difficulties | Mental healthUKBB0000033811.42
393LGALS8/SOD2 ratioGCST9031532011.42
394Types of physical activity in last 4 weeks - None of the above | Physical activityUKBB0000087211.31
395Time spent driving | Physical activityUKBB0000081811.25
396Salty food likingGCST9009482811.22
397QPCT levelsGCST9047040111.21
398SNX15 levelsGCST9047069911.20
399Atopic/contact dermatitis due to other or unspecified (PheCode 939)GCST9047628911.18
400HypothyroidismGCST9046813811.17
401Handedness (confirmatory factor analysis Factor 36)GCST9030937011.12
402MAPRE3 levelsGCST9046985911.11
403Thyroid peroxidase antibody positivity in pregnancyGCST9043520211.09
404Pure hyperglyceridaemiaFING0000123111.09
405RCC1 levelsGCST9047044311.05
406REST UKBBICA NODEamps25 0003GCST9038548611.04
407NME3 levelsGCST9047005511.04
408Tyrosine levelsGCST9020042711.03
409Right-hemisphere somatomotor network to pallidum white-matter structural connectivityGCST9030279711.02
410Eosinophill count | Blood countUKBB0000020611.01
411Diseases of white blood cells (PheCode 288)GCST9047581211.01
412ADD1 levelsGCST9046823310.95
413Congestive heart failure; nonhypertensive (PheCode 428)GCST9047598110.94
414Eosinophill percentage | Blood countUKBB0000020710.93
415PAM levelsGCST9047015610.92
416Mean sphered cell volume (UKB data field 30270)GCST9046808910.92
417T1 CAT volume L LeftPutamenGCST9038410010.88
418CD40/IGSF8 ratioGCST9031381510.88
419CD20 on IgD- CD27- B cellGCST9000175410.87
420Ceramide (d17:1/24:0) levelsGCST9002403310.87
421X-21467 levelsGCST9020059410.84
422Cereal type - Oat cereal (e.g. Ready Brek, porridge) | DietUKBB0000012410.84
423Right ventricular ejection fraction (MTAG)GCST9013459510.84
424IL12A_IL12B/LAG3 ratioGCST9031514710.83
425ARL13B levelsGCST9046836310.82
426Blood cell traits latent factor 12 (red cell)GCST9055925410.82
427DTI TBSS L1 Cingulum cingulate gyrus LGCST9038446310.80
428NOTCH1/SEMA7A ratioGCST9031554510.79
429CFHR2 levelsGCST9046872610.76
430Graves' diseaseGCST9001862710.75
431Carcinoma in situ of breast, intraductal (controls excluding all cancers)FING0000024010.75
432Lamb likingGCST9009479010.74
433Pain in joint (PheCode 745)GCST9047626210.74
434red blood cell count (RBC, mean, inv-norm transformed)GCST9047634710.70
435Right-hemisphere salience/ventral attention network to thalamus white-matter structural connectivityGCST9030281710.70
436RAP1A levelsGCST9047042510.69
437Skin color (cheek, ITA value)GCST9050278010.69
438Thyroid peroxidase antibody levels in pregnancyGCST9043520110.68
439Principal component-derived dietary pattern 28GCST9013303310.68
440AppendectomyFING0000010410.67
441CILP levelsGCST9046875410.66
442CD79B levelsGCST9046864810.65
443Salami likingGCST9009482510.62
444DTI autoptx FA ilf r tractGCST9038512710.61
445T1 CAT volume R TemporalFusiformCortexposteriordivisionGCST9038407510.59
446PECAM1/SOD2 ratioGCST9031564710.57
447MAMDC4 levelsGCST9046984210.56
448Psoas tendinitisFING0000122110.54
449Transient global amnesiaFING0000137410.53
450Types of transport used (excluding work) - Public transport | Physical activityUKBB0000087810.51
451ADGRE2 levelsGCST9046823710.50
452Sphingomyelin_33:1_[M+H]1+ levelsGCST9006022910.48
453FOXO1/MAP4K5 ratioGCST9031487210.42
454PDGFRB levelsGCST9047019210.37
455Lamb or mutton consumption (UKB data field 1379)GCST9013299810.37
456Eosinophil countGCST9002598710.34
457BA-exvivo rh area BA45GCST9000322910.33
458Triacylglycerol_52:3_[M+NH4]1+ levelsGCST9006050910.32
459Liver likingGCST9009479410.32
460Thyroid cancer (PheCode 193)GCST9047560010.32
461CCL17/PDGFB ratioGCST9031368810.31
462Osteochondrodysplasia with defects of growth of tubular bones and spineFING0000091010.27
463IL12A or IL12B levelsGCST9046954810.25
464PTPN1/WWP2 ratioGCST9031574610.25
4651,5-anhydroglucitol (1,5-ag) levelsGCST9024352910.24
466Recent inability to stop or control worrying | AnxietyUKBB0000074210.23
467Syncope and collapse | symptomsUKBB0000080110.20
468Biological Mother: Coronary Artery / Coronary Heart DiseaseGCST9047548810.16
469Types of physical activity in last 4 weeks - Heavy DIY (eg: weeding, lawn mowing, carpentry, digging) | Physical activityUKBB0000087010.15
470CD84/TREML2 ratioGCST9031391910.14
471Duration walking for pleasure | Physical activityUKBB0000020310.14
472TNFRSF11A levelsGCST9027764410.14
473Educational attainmentGCST00259810.13
474C1QTNF1/COL18A1 ratioGCST9031355110.12
475Lysoalkylphosphatidylcholine (O-24:0) levelsGCST9002543610.11
476FAS levelsGCST9046919210.10
477Schizophrenia or delusion (more control exclusions)FING0000127810.08
478Allergic conjunctivitisFING0000006710.08
479Right-hemisphere somatomotor network to amygdala white-matter structural connectivityGCST9030279910.06
480S100P levelsGCST9047052010.02
481IDP T1 FAST ROIs R cerebellum VGCST9000256510.01
482Seborrheic keratosis (PheCode 702.2)GCST9047620610.00
483Takes medication for Thyroid problems?GCST904752779.97
484Mean reticulocyte volumeGCST900259759.97
485HAVCR2 levelsGCST904215159.96
486LSP1 levelsGCST904698119.94
487Cervicobrachial syndromeFING000002669.91
488PRTG levelsGCST904703479.89
489IL22 levelsGCST904695829.88
490Current employment status - In paid employment or self-employed | EmploymentUKBB000001589.86
491Triacylglycerol_52:1_[M+NH4]1+ levelsGCST900605159.82
492Spinal stenosis | musculoskeletalUKBB000007929.80
493Other diseases of upper respiratory tractFING000010129.77
494PFKM levelsGCST906188029.77
495Omega-3 fatty acid levelsGCST905024229.75
496Wears glasses or contact lenses (UKB data field 2207)GCST900428759.74
497Beef/steak likingGCST900947009.74
498TNFRSF9 levelsGCST904709169.72
499Operation code - tonsillectomy +/- adenoids | OperationsUKBB000005679.72
500CD5/TNFRSF9 ratioGCST903138629.72
501Soft tissue disordersFING000013169.68
502CXCL11 levelsGCST902747819.65
503aparc-DKTatlas lh thickness paracentralGCST900035559.65
504Autoimmune diseasesFING000001319.64
505T1 CAT volume R RightAccumbensGCST903841099.64
506Strawberries likingGCST900948499.61
507Heart failure with reduced EF [Systolic or combined heart failure] (PheCode 428.3)GCST904759839.61
508Obstructive sleep apnea (PheCode 327.32)GCST904758259.59
509Left-hemisphere limbic network to right-hemisphere salience/ventral attention network white-matter structural connectivityGCST903027329.59
510CNTNAP4 levelsGCST904688099.57
511FAM151A levelsGCST902424509.57
512Internal derangement of knee | injuries & poisoningsUKBB000003689.56
513IDP dMRI TBSS FA Posterior thalamic radiation LGCST900039069.55
514Age when finished full-time education (standard GWA)GCST902672809.54
515SEMA4C levelsGCST904705729.54
516Carnitine levelsGCST901996219.54
517T1 FreeSurfer aseg Right-PutamenGCST903841639.51
518Psoriasis (PheCode 696.4)GCST904761879.51
519Use of dietary supplements (confirmatory factor analysis Factor 13)GCST903093479.50
520NFATC3 levelsGCST904700349.50
521TCN2 levelsGCST904708209.48
522Eosinophil percentage of white cellsGCST900023829.47
523Psoriasis vulgaris (PheCode 696.41)GCST904761909.44
524Mosaic chromosomal alteration of the X chromosomeGCST901652879.43
525ADGRE5/VCAM1 ratioGCST903131849.42
526aseg lh intensity Cerebellum-CortexGCST900037679.41
527Congenital lactase deficiencyFING000003299.39
528TNFRSF8/TNFRSF9 ratioGCST903159409.38
529Percentage of fucosylated structures (with bisecting GlcNAc) in total neutral plasma glycans (GP80)GCST906685249.36
530LYN/TACC3 ratioGCST903153509.35
531Mean sphered cell volume | Blood countUKBB000004529.33
532Spleen volumeGCST900166679.33
533SNAP25 levelsGCST904220839.33
534Eustachian tube disorders (PheCode 381.2)GCST904759049.32
535Ever worried more than most people would in similar situation | AnxietyUKBB000002279.30
536Triacylglycerol_48:3_[M+NH4]1+ levelsGCST900604189.29
537Eosinophil countGCST900023819.27
538RTBDN levelsGCST904705059.27
539CD160/NCR1 ratioGCST903137329.25
540EZR levelsGCST904691629.24
541Drinks usually with meals in current drinkers (yes and it varies vs no) (UKB data field 1618)GCST901329259.22
542CTSC levelsGCST904689099.22
543Triglyceride levels in very large HDLGCST901326369.18
544Subjective well-beingGCST901048979.17
545CHI3L1/PRSS8 ratioGCST903140449.16
546Substance use, excluding alcoholFING000013429.15
547MS-disease / Multiple SclerosisFING000008399.14
548C1QL2 levelsGCST904684879.14
549Omega-3 fatty acids to total fatty acids percentageGCST905024489.13
550CDHR1 levelsGCST904686789.12
551Left ventricular end diastole inferoseptal wall thicknessGCST902785149.11
552ERP29 levelsGCST900888439.10
553Principal component-derived dietary pattern 9GCST901330149.10
554Graves disease, strict definitionFING000005929.10
555Hypothyroidism, strict autoimmuneFING000006569.09
556CCL5/SELP ratioGCST903137059.09
557Repeated disturbing thoughts of stressful experience in past month | Traumatic eventsUKBB000007509.08
558Aniseed likingGCST900946899.07
559PLXNB2 levelsGCST904702669.07
560CNTNAP2 levelsGCST904688089.02
561Comfortable retirement (confirmatory factor analysis Factor 29)GCST903093639.02
562ANPEP/CXADR ratioGCST903132728.97
563Eosinophill percentage (UKB data field 30210)GCST904680698.97
564Poisoning by antibiotics | injuries & poisoningsUKBB000006538.97
565EFNA4/TNFRSF9 ratioGCST903146068.96
566CABP2 levelsGCST904685198.93
567HippSubfield rh volume presubiculum-headGCST900026958.93
568rfMRI connectivity (ICA100 edge 495)GCST900053488.92
569IDP T1 FAST ROIs L subcallosal cortexGCST900025038.90
570Ratio of bis-allylic bonds to double bonds in lipidsGCST901327448.89
571ICAM3/LY9 ratioGCST903151218.89
572SKAP1 levelsGCST904706458.88
573Dizziness and giddiness (Light-headedness and vertigo) (PheCode 386.9)GCST904759088.87
574Diseases of external earFING000004248.86
575Gastroesophageal reflux diseaseGCST900005148.86
576CCDC50 levelsGCST904685618.85
577PDGFA/USP8 ratioGCST903156218.84
578Nerve, nerve root and plexus disordersFING000008628.83
579POSTN levelsGCST904702888.81
580ChalazionFING000002678.81
581Cereal type - Muesli | DietUKBB000001238.81
582Osteoarthrosis, localized, primary (PheCode 740.11)GCST904762558.78
583MGAT2 levelsGCST900895608.78
584Asthma (adult onset)GCST0077998.78
585HypothyroidismGCST903193208.77
586Urine N1,N12-diacetylspermine levels in chronic kidney diseaseGCST902656838.76
587AV-blockFING000001378.75
588Mineral and other dietary supplements - None of the above | MedicationUKBB000004748.74
589F-cooking flavour liking (derived food-liking factor)GCST900947428.74
590CD164/CD99 ratioGCST903137408.74
591wg rh intensity-contrast superiorfrontalGCST900038548.73
592SEMA7A levelsGCST904705758.73
593Use of hypnotics and sedativesFING000014118.73
594T1 CAT GM unnormalised volumeGCST903839828.72
5951-stearoyl-2-oleoyl-GPS (18:0/18:1) levelsGCST901996528.71
596All pneumoniaeFING000000658.71
597UCMA levelsGCST902432858.70
598Psoriatic arthropathiesFING000012258.69
599Triacylglycerol_51:3_[M+NH4]1+ levelsGCST900604948.68
600T1 CAT volume R RightThalamusGCST903840978.68
601Social trust (aggregated)GCST903193158.66
602T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 102)GCST903206658.63
603CXCL5/PLXNA4 ratioGCST903143518.63
604Psoriasis and related disorder (PheCode 696)GCST904761868.61
605Cardiorespiratory fitness slopeGCST900933208.60
606Estradiol levelsGCST900121058.58
607Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T276ECGU0002768.58
608Loneliness, isolation | Mental healthUKBB000004088.57
609Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T305ECGA0003058.57
610HippSubfield rh volume CA1-bodyGCST900026928.54
611ACY1/SCLY ratioGCST903131658.54
612FOLH1 levelsGCST904256618.54
613Family relationship satisfaction | Mental healthUKBB000002388.53
614X-11787 levelsGCST902004658.53
615Postinflammatory pulmonary fibrosis (PheCode 502)GCST904760328.52
616Participation in an health questionnaire (not invited vs invited)GCST900127948.51
617VAMP5 levelsGCST904710248.51
618GOLM2/ITGA5 ratioGCST903149518.50
619Chronic diseases of tonsils and adenoidsFING000002838.50
620Cereal type: Muesli (UKB data field 1468_4)GCST901329728.48
6214-androsten-3beta,17beta-diol disulfate 1 levelsGCST902438798.48
622Other hypothyroidism | Disorders of thyroid glandUKBB000006118.48
623DTI TBSS FA Posterior thalamic radiation LGCST903844098.46
624HypothyroidismGCST902041678.46
625CLEC4C levelsGCST904687728.45
626Ulcerative colitisGCST900187138.44
627Bread type: Wholemeal/wholegrain vs white and brown (UKB data field 1448)GCST901329688.44
628CD244/CRTAM ratioGCST903137638.42
629Erythematosquamous dermatosis (PheCode 690)GCST904761708.42
630Tryptophan betaine levelsGCST901998198.39
631FGF21 levelsGCST902747888.38
632PADI2 levelsGCST904701428.38
633TDRKH/TST ratioGCST903159138.35
634THBS2 levelsGCST904708548.34
635ATP5IF1/FXN ratioGCST903133868.33
636Eosinophil countGCST900022988.33
637Prescriptions - antispasmodicUKBB000006668.32
638Medication use (glucocorticoids)GCST900187808.32
639ZP3 levelsGCST904711058.29
640CSNK1D levelsGCST904688888.29
641Eosinophil percentage of white cellsGCST0046008.28
642SLAMF7 levelsGCST904706518.27
643DCTN6/TDRKH ratioGCST903144368.27
644Eosinophill count (UKB data field 30150)GCST904680688.27
645Neutrophils and lymphocytes in blood (confirmatory factor analysis Factor 35)GCST903093698.24
646CD48/CRTAM ratioGCST903138398.23
647GABBR2 levelsGCST902412308.22
648Bread type: Wholemeal or wholegrain (UKB data field 1448_3)GCST901329668.22
649DAB2/FKBP1B ratioGCST903143628.22
650Usual side of head for mobile phone use - Left | Electronic device useUKBB000008898.21
651Phenylalanine levelsGCST900929368.20
652MGLL/MITD1 ratioGCST903154368.20
653LGALS3BP levelsGCST904697608.20
654Number of non-cancer illnesses (standard GWA)GCST902672908.19
655TNFSF14 levelsGCST904709228.18
656HippSubfield rh volume subiculum-headGCST900026938.18
657Hypothyroidism NOS | endocrine/metabolicUKBB000003368.17
658CCL3 levelsGCST900120558.17
659Reimbursement for rheumatic diseasesFING000012478.17
660ARHGAP30 levelsGCST904683548.17
661ECG, load | ECG during exerciseUKBB000002058.13
662Smoking status (standard GWA)GCST902673028.13
663Diacylglycerol_34:3_[M+H-H2O]1+ levelsGCST900601778.11
664FABP1/SULT2A1 ratioGCST903147558.11
665AXIN1/SRPK2 ratioGCST903134178.09
666Autoimmune hyperthyroidismFING000001348.08
667wg rh intensity-contrast lateraloccipitalGCST900038378.08
668Estradiol levelsGCST900200918.07
669Brussel sprout likingGCST900947148.07
670CAPN3 levelsGCST904685388.04
671Eosinophil countGCST0046068.04
672Acceptance of an invitation to participate in a mental health questionnaireGCST900127928.04
673Other systemic involvement of connective tissue (FG)FING000011168.03
674Nephrotic syndromeGCST900186648.01
675Seborrheic dermatitis (PheCode 690.1)GCST904761718.01
676aparc-a2009s rh thickness G-temporal-middleGCST900037148.01
677aseg rh volume AmygdalaGCST900026428.01
678Hypothyroidism | endocrine/metabolicUKBB000003357.98
679DTI TBSS L3 Sagittal stratum LGCST903845557.95
680IL12B levelsGCST904695497.94
681GZMA/LTA ratioGCST903150127.94
682Respiratory disease (confirmatory factor analysis Factor 11)GCST903093457.94
683Rubneribacter sp002159915 abundance in stoolGCST900325417.93
684Left ventricular end diastolic massGCST902681237.93
685CD22/CD79B ratioGCST903137557.91
686Ventricular arrhythmiaGCST900187207.89
687SERPINE1/USP8 ratioGCST903158357.89
688Light-intensity physical activity durationGCST900614217.87
689Conditional arithmetic | Fluid intelligence / reasoningUKBB000001457.86
690Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T284ECGU0002847.85
691DRAXIN levelsGCST904690387.84
692Alcohol usually taken with meals (UKB data field 1618)GCST901330047.84
693Cardiorespiratory fitness (vo2 max)GCST900933167.83
694Age when finished full-time education (weighted GWA)GCST902672817.80
695Mean spheric corpuscular volumeGCST900023977.80
696X-12063 levelsGCST902436877.77
697ADGRE5/SEMA7A ratioGCST903131837.77
698Mean carotid IMT (intima-medial thickness) at 240 degrees | Carotid ultrasoundUKBB000004467.77
699Late-onset myasthenia gravisGCST904321587.76
700CRYGD levelsGCST904688767.74
701aparc-a2009s lh volume S-circular-insula-supGCST900029737.73
702TNFRSF6B levelsGCST904709147.73
703Age hay fever, rhinitis or eczema diagnosed | Medical conditionsUKBB000000157.71
704Disorders of the thyroid glandFING000004637.71
705Time to complete round | Pairs matchingUKBB000008227.70
706Skin sebum (glabella)GCST905027977.70
707ATOX1/TMSB10 ratioGCST903133777.69
708Cholesteryl ester (16:2) levelsGCST900246287.69
709PADI4 levelsGCST904701437.68
710Telomere length (principal component 1)GCST904351447.66
711MANSC1/PODXL2 ratioGCST903153717.66
712DTI TBSS L2 Posterior thalamic radiation RGCST903845047.66
713MAP3K5/MAVS ratioGCST903153797.64
714CD200/CLEC4G ratioGCST903137467.64
715TNFRSF4/TNFRSF8 ratioGCST903159387.64
716Cancer of urinary organs (incl. kidney and bladder) (PheCode 189)GCST904755937.63
717Clonal hematopoiesis (large clone)GCST901026217.62
718Urine 16a-hydroxy DHEA 3-sulfate levels in chronic kidney diseaseGCST902643297.62
719IRAG2/TBC1D23 ratioGCST903151917.60
720IDP T1 FAST ROIs L postcent gyrusGCST900024837.59
721IFI30 levelsGCST904695097.58
722COL9A1 levelsGCST904688227.56
723DTI autoptx FA ifo r tractGCST903851257.56
724LTA levelsGCST904698137.55
725DTI autoptx FA ptr l tractGCST903851317.55
726BAG6/BMP6 ratioGCST903134507.55
727CEP43/USP8 ratioGCST903140227.53
728CEACAM8 levelsGCST904686987.53
729mean corpuscular volume (MCV, mean, inv-norm transformed)GCST904754707.51
730LCN2/PGLYRP1 ratioGCST903153067.51
731AmygNuclei lh volume Central-nucleusGCST900026527.50
732Minimum carotid IMT (intima-medial thickness) at 210 degrees | Carotid ultrasoundUKBB000004777.48
733AsthmaGCST0100427.47
734T1 FreeSurfer a2009s rh S temporal sup volumeGCST903851107.47
735Physical activity (Total log acceleration 8am-10am)GCST900614137.46
736Prescriptions - amlodipine | calcium channel blocker,dihydropyridine,anti-hypertensiveUKBB000006607.45
737GDI2 levelsGCST900880047.43
738HippSubfield rh volume CA4-bodyGCST900027057.43
739Mean reticulocyte volume | Blood countUKBB000004517.42
740Number of sexual partners in opposite-sex sexual behaviorGCST900264817.38
741PLXNB2/SEMA7A ratioGCST903156927.38
742aseg rh intensity Cerebellum-CortexGCST900037817.37
743T1 FreeSurfer aseg Left-CaudateGCST903841447.36
744HippSubfield lh volume GC-ML-DG-bodyGCST900026817.35
745Usual side of head for mobile phone use - Right | Electronic device useUKBB000008907.35
746CCS levelsGCST904685947.35
747FABP1 levelsGCST904691737.34
748Treatment/medication code - lansoprazole | MedicationsUKBB000008487.34
749DNAJB2 levelsGCST904690137.34
750IDP dMRI TBSS L2 Posterior thalamic radiation LGCST900041527.34
751Lymphoplasmacytic lymphoma and Waldenstrom macroglobulinemiaGCST906247447.33
752Coffee type: Decaffeinated coffee (any type) (UKB data field 1508_1)GCST901329747.32
753Early-onset myasthenia gravisGCST900934657.31
754ATF6 levelsGCST902408167.31
755CD48/FCRL6 ratioGCST903138407.30
756Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor - None of the above | Medical conditionsUKBB000001017.30
757Non-cancer illness code, self-reported - asthma | Medical conditionsUKBB000005067.28
758rfMRI connectivity ICA-features 6GCST900063447.27
759Financial situation satisfaction | Mental healthUKBB000002497.27
760Methods of discharge from hospital (recoded) - Discharged on clinical advice/consent | Summary AdministrationUKBB000004667.26
761Disorders of other endocrine glandsFING000004507.25
762mean corpuscular volume (MCV, maximum, inv-norm transformed)GCST904754667.25
763LRIG3 levelsGCST904697957.23
764Androstenediol (3beta,17beta) disulfate (2) levelsGCST901998517.22
765CXCL10 levelsGCST902747807.22
766Soy sauce likingGCST900948447.22
767Ulcerative rectosigmoiditisFING000013947.21
768RASSF2 levelsGCST904704317.21
769Drive faster than motorway speed limit | Physical activityUKBB000001947.20
770GALNT5 levelsGCST904692987.20
771Feeling lonelyGCST0069427.20
772Cervical cancerGCST900185977.20
773Suicide or other Intentional self-harmFING000013457.20
774Birth year infant mortality ratesGCST900950477.19
775wg lh intensity-contrast superiorfrontalGCST900038197.18
776Suppurative and unspecified otitis mediaFING000013467.18
777CD27/FCRL5 ratioGCST903137727.17
778Number of operations, self-reported | OperationsUKBB000005397.16
779Thyroid peroxidase antibody positivity with euthyroid in pregnancyGCST904352037.16
780BIN1 levelsGCST900907577.16
781DTI autoptx FA ifo l tractGCST903851247.13
782Ulcerative colitis (PheCode 555.2)GCST900441557.13
783mean corpuscular volume (MCV, minimum, inv-norm transformed)GCST904754747.13
784Red wine consumption (glasses per month) (UKB data field 1578, 4419)GCST901329877.12
785Plasma glycocholenate sulfate* levels in chronic kidney diseaseGCST902652917.10
786IDP T1 FAST ROIs L cerebellum XGCST900025877.09
787VEGFB levelsGCST904710357.08
788Dissociative [conversion] disordersFING000004687.08
789Cerebrospinal fluid 5-methylthioadenosine (MTA) levelsGCST903182167.08
790Left-hemisphere control network to caudate white-matter structural connectivityGCST903027537.07
791DTI TBSS L2 Posterior thalamic radiation LGCST903845057.07
792GFRA2 levelsGCST904693297.07
793Squamous cell carcinoma (PheCode 172.22)GCST904755837.06
794Prescriptions - calcium channel blocker|dihydropyridine|anti-hypertensiveUKBB000006737.06
795Total Phosphatidylethanolamine levelsGCST900252077.05
796ARHGAP25/RNF41 ratioGCST903133457.05
797EFNA4 levelsGCST904690817.05
798SIT1 levelsGCST904706447.05
799ADH4/CA5A ratioGCST903131897.02
800Clonal haematopoiesis of indeterminate potential (TET2 mutation)GCST901652817.02
801Sedentary behavior at workGCST901043457.01
802KLRB1 levelsGCST904697097.00
803CHRDL1 levelsGCST904687506.99
804NPC2 levelsGCST904700686.98
805GALNT10/SEMA7A ratioGCST903149156.97
806PPP1R2/USP8 ratioGCST903157236.96
807Attendance/disability/mobility allowance - Disability living allowance | Other sociodemographic factorsUKBB000000586.95
808ENPP5 levelsGCST904691166.94
809wg lh intensity-contrast lingualGCST900038046.94
810BAMBI levelsGCST904684206.93
811CRTAM levelsGCST904688716.90
812CD244 levelsGCST902747716.87
813TNF/TNFRSF1B ratioGCST903159426.86
814Vitamin D levelsGCST0053676.86
815ADGRE1 levelsGCST904682366.84
816Physical activity (Total log acceleration)GCST900614086.83
817DKK3 levelsGCST904689986.83
818T1 FreeSurfer aseg Right-PallidumGCST903841646.83
819F-highly palatable foods liking (derived food-liking factor)GCST900947856.83
820Anxiety disorders (more control exclusions)FING000000986.82
821Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T283ECGU0002836.82
822Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T229ECGU0002296.81
823Educational attainmentGCST0034966.78
824CLEC4G/NELL2 ratioGCST903141226.78
825Blood cell traits latent factor 9 (white cell)GCST905592516.77
826Crohn's diseaseGCST0041326.76
827Smoking status (weighted GWA)GCST902673036.75
828CCL16 levelsGCST904685686.74
829PsoriasisGCST904681476.74
830FABP1/LGALS4 ratioGCST903147526.73
831NUDT5/TXNRD1 ratioGCST903155826.72
832Emotionally unstable personality disorderFING000004956.71
833T1 FreeSurfer a2009s rh S temporal sup areaGCST903849626.71
834Volume of right whole amygdalaGCST904750546.71
835Eosinophil percentage of granulocytesGCST0046176.70
836Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T275ECGU0002756.70
837Mean reticulocyte volume (UKB data field 30260)GCST904680886.70
838Omega-3 fatty acids to total fatty acids percentageGCST905024606.70
839Psoriasis (vulgaris), strict definitionFING000012236.69
840Chicken likingGCST900947326.68
841DNA methylation PhenoAge accelerationGCST900142926.67
842CCL3 levelsGCST904685826.67
843Red cell distribution width varianceGCST905657056.67
844Burger likingGCST900947156.67
845Acute upper respiratory infectionsFING000000346.66
846Systemic connective tissue disordersFING000013506.65
847Apples likingGCST900946916.64
848ISEI occupational scoreGCST904461606.64
849Other disorders of the musculoskeletal system and connective tissueFING000010386.64
850CEACAM8/PGLYRP1 ratioGCST903140036.63
851Congestive heart failure (CHF) NOS (PheCode 428.1)GCST904759826.63
852Heart failure with preserved EF [Diastolic heart failure] (PheCode 428.4)GCST904759846.62
853Mean corpuscular hemoglobin concentrationGCST900187456.61
854Diarrhoea and gastroenteritis of presumed infectious originFING000004206.60
855Triglycerides x depression interaction (2df test)GCST905706796.60
856Asthma (childhood onset)GCST0078006.60
857IDP T1 FAST ROIs R postcent gyrusGCST900024846.60
858aseg rh number HolesBeforeFixingGCST900026476.60
859BA-exvivo rh area BA6GCST900032276.59
860Dementia due to Parkinson's disease (more control exclusions)FING000003926.58
861Frequency of heavy DIY in last 4 weeks | Physical activityUKBB000002636.58
862CD163/ICAM1 ratioGCST903137356.57
863DIABLO/PDGFB ratioGCST903144686.56
864Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T304ECGA0003046.55
865Lymphocyte percentage of white cellsGCST900023896.55
866Hair colour (natural, before greying) - Dark brown | Sun exposureUKBB000002976.54
867eosinophil (fraction, mean, inv-norm transformed)GCST904753006.54
868IDP T1 FAST ROIs L cerebellum VIGCST900025666.53
869Shortness of breath (PheCode 512.7)GCST904760406.53
870Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor - Asthma | Medical conditionsUKBB000000986.52
871F-strong flavour liking (derived food-liking factor)GCST900948516.50
872CA1/HMBS ratioGCST903135736.50
873Any mental disorderFING000001006.50
874CD244/TREML2 ratioGCST903137676.49
875Age at first sexual intercourseGCST900000456.47
876Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T287ECGU0002876.47
877rfMRI amplitudes (ICA100 node 27)GCST900046156.47
878MGLL/STK4 ratioGCST903154436.46
879ADM levelsGCST904682466.45
880CRTAM/VCAM1 ratioGCST903142816.45
881PGLYRP1 levelsGCST904702196.44
882PTN levelsGCST904703746.44
883Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor - Hayfever, allergic rhinitis or eczema | Medical conditionsUKBB000001006.44
884Non-cancer illness code, self-reported - diabetes | Medical conditionsUKBB000005086.43
885Mean reticulocyte volumeGCST900023966.42
886Ceramide (d17:1/22:0) levelsGCST900240326.42
887MMP1 levelsGCST904699196.42
888Sum eosinophil basophil countsGCST0046246.40
889Illness, injury, bereavement, stress in last 2 years - None of the above | Mental healthUKBB000003396.39
890Chronic obstructive pulmonary disease in current smokersGCST900165936.37
891aparc-DKTatlas rh thickness lingualGCST900035826.37
892PLAUR levelsGCST900120516.35
893Diseases of the digestive systemFING000004296.32
894Other and/or unspecified nontoxic goitreFING000009586.32
895Second line medication for Crohn's diseaseFING000012846.32
896Mid-point of the five least active hours of the dayGCST900614346.31
897Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T277ECGU0002776.30
898CD20 on IgD- CD38- B cellGCST900017556.30
899AK1 levelsGCST904682696.30
900Omega-6 fatty acid levelsGCST905025196.29
901Plasma X-26054 levels in chronic kidney diseaseGCST902668586.27
902Lichen ruber planus, wide definition including periferal and oral lichen planusFING000007226.27
903Autoimmune diseases excluding thyroid diseasesFING000001326.27
904lymphocyte (fraction, minimum, inv-norm transformed)GCST904754386.26
905LAIR2 levelsGCST904697296.26
906Insomnia (weighted GWA)GCST902672876.24
907Ulcerative colitis (strict definition, require KELA, min 2 HDR)FING000013886.23
908Non-cancer illness code, self-reported - hayfever/allergic rhinitis | Medical conditionsUKBB000005136.22
909GZMB levelsGCST904694246.22
910Hair colour (natural, before greying): Dark brown (UKB data field 1747_4)GCST900418396.21
911PDGFA/SPARC ratioGCST903156206.21
912Meniscus derangementFING000008076.21
913PPP2R2A levelsGCST906181226.21
914Uterine fibroidsGCST904681546.20
915RNASET2 levelsGCST904704816.18
916Insomnia (PheCode 327.4)GCST904758266.18
917N-formylanthranilic acid levelsGCST901999606.17
918SULT2A1 levelsGCST904707826.17
919Frequency of tiredness / lethargy in last 2 weeks | Mental healthUKBB000002686.16
920Lymphocyte percentage (UKB data field 30180)GCST904680836.16
921ITGB1BP2/PTPN6 ratioGCST903152186.15
922PPP1R2/TACC3 ratioGCST903157196.15
923GDNF levelsGCST902747926.14
924neutrophil (fraction, mean, inv-norm transformed)GCST904755386.14
925T1 FreeSurfer aseg Right-choroid-plexusGCST903841706.13
926FCAMR levelsGCST904691966.13
927IDP dMRI ProbtrackX OD str lGCST900044736.12
928Principal component-derived dietary pattern 12GCST901330176.12
929Body-mass index, inverse-rank normalizedFING000002226.11
930FCRL3 levelsGCST904692076.11
931Physical activityGCST900933226.11
932ST6GAL1 levelsGCST904707536.11
933Asthma-related infectionsFING000001186.11
934TAX1BP3 levelsGCST902429766.11
935Current employment status - Retired | EmploymentUKBB000001596.10
936Diabetes mellitus | endocrine/metabolicUKBB000001696.10
937Diabetes (weighted GWA)GCST902672796.10
938MEPE levelsGCST904698896.09
939CEACAM8/VNN2 ratioGCST903140056.08
940Loneliness (standard GWA)GCST902672886.07
941wg rh intensity-contrast precentralGCST900038506.06
942LCN2/PRTN3 ratioGCST903153076.04
943Gut bacterial pathway abundance (PYRIDNUCSYN.PWY..NAD.biosynthesis.I..from.aspartate.)GCST900276386.04
944CEBPB levelsGCST904687006.04
945TriglyceridesGCST900187556.04
946T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 121)GCST903206846.03
947HDAC8 levelsGCST904694386.03
948IDO1 levelsGCST904695066.03
949Irritable bowel syndromeFING000007026.03
950Asthma and allergyFING000001156.02
951Vitamin B12 deficiency anaemiaFING000014416.01
952PBLD levelsGCST904701636.00
953PDCD6IP levelsGCST906189696.00
954XRCC4 levelsGCST904710856.00
955Coffee type: Ground coffee (include espresso, filter etc) (UKB data field 1508_3)GCST900418035.99
956TSC1 levelsGCST904709725.98
957F-sweetened coffee drink liking (derived food-liking factor)GCST900948535.98
958CD20 on IgD- CD24- B cellGCST900017535.98
959Right-hemisphere control network to right-hemisphere control network white-matter structural connectivityGCST903028345.98
960Lysoalkylphosphatidylcholine (O-24:0) levelsGCST900241975.97
961IL2RB levelsGCST904695865.96
962Pollen allergyFING000011765.95
963PITHD1 levelsGCST904702395.95
964Left-hemisphere control network to amygdala white-matter structural connectivityGCST903027575.95
965Right ventricular ejection fractionGCST902681175.94
966LAYN/VWC2 ratioGCST903152935.93
967Ptosis of eyelidFING000012275.92
968Lysoalkenylphosphatidylethanolamine (P-20:0) levelsGCST900254605.92
969Coeliac diseaseFING000003125.92
970F-wine liking (derived food-liking factor)GCST900948725.91
971Sleep disorders (PheCode 327)GCST904758235.90
972Mean platelet thrombocyte volume (UKB data field 30100)GCST904680875.90
973Working memoryGCST905031165.88
974Neutrophil percentage of granulocytesGCST0046235.88
975Bacterial pneumoniaeFING000001395.88
976Percentage of fucosylation of monogalactosylated structures (with bisecting GlcNAc) in total neutral plasma glycans (GP82)GCST906685265.88
977PLXNA4/SRPK2 ratioGCST903156885.88
978DTI TBSS L1 Splenium of corpus callosumGCST903844325.87
979PolyarthropathiesFING000011805.87
980CTSZ/HSPG2 ratioGCST903143185.86
981CCN2/VEGFC ratioGCST903137195.85
982Vitamin and mineral supplements - None of the above | MedicationUKBB000009015.85
983F9/FURIN ratioGCST903147475.84
984HayfeverGCST904681315.84
985IDP dMRI ProbtrackX FA fmaGCST900039355.84
986DNMBP/WWP2 ratioGCST903145225.83
987Inflammatory bowel disease, strict (require KELA)FING000006755.83
988DMP1 levelsGCST904690075.82
989Other peripheral nerve disorders (PheCode 351)GCST904758425.82
990Gestational [pregnancy-induced] oedema and proteinuria without hypertensionFING000005725.82
991ExotropiaGCST905727375.80
992CD6/EZR ratioGCST903138905.80
993IGSF21 levelsGCST904695385.80
994Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T149ECGU0001495.80
995DBNL/VASH1 ratioGCST903144275.79
996Takes medication for skin cancer?GCST904751905.79
997FXYD5/TMSB10 ratioGCST903149065.79
998Type1 diabetes, definitions combined, early onsetFING000013845.79
999Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T281ECGU0002815.79
1000Breast cancer (PheCode 174)GCST904356005.78